Cancer Immunotherapy Month | Immunotherapy Minute: Aravindabharthi Ramakrishnan, PhD

Spend a minute with Dr. Aravindabharthi Ramakrishnan, a CRI postdoctoral fellow working at Boston Children’s Hospital, as he discusses the curiosity that led to becoming a researcher and what informs his work.
--
Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. www.cancerresearch.org
Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.